These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6956734)

  • 1. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J; Surrago EJ
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories.
    Hochman M; Laufe LE
    J Reprod Med; 1976 May; 16(5):263-8. PubMed ID: 933105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of prostaglandins and their analogues for abortion.
    Bygdeman M
    Clin Obstet Gynaecol; 1984 Dec; 11(3):573-84. PubMed ID: 6391777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
    Lebed JP; Rubin A; Millman AE
    Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intra-amniotic (15S)-15-methyl-PGF2 alpha and intravaginal prostaglandin E2 for second-trimester uterine evacuation.
    Perry KG; Roberts WE; Martin RW; Magann EF; Sullivan DL; Morrison JC
    J Perinatol; 1998; 18(1):24-7. PubMed ID: 9527940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
    Hagar DL; Valley MT; Rayburn WF; Carey JC
    J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D & E midtrimester abortion: a medical innovation.
    Lewit S
    Women Health; 1982; 7(1):49-55. PubMed ID: 7180000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
    Corson SL; Bolognese RJ
    J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 vaginal suppositories for therapeutic abortion.
    Newman C; Bailey CD; Ellinas SP; Anderson GG
    Adv Plan Parent; 1975; 10(1):34-8. PubMed ID: 1164986
    [No Abstract]   [Full Text] [Related]  

  • 13. Mid-trimester abortion using hypertonic saline or prostaglandin E2 gel: an analysis of efficacy and complications.
    Herabutya Y; O-Prasertsawat P
    J Med Assoc Thai; 1994 Mar; 77(3):148-52. PubMed ID: 7798849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midtrimester pregnancy termination: a study of the cost effectiveness of dilation and evacuation in a free-standing facility.
    Crist T; Williams P; Lee SH; Hulka JF
    N C Med J; 1983 Sep; 44(9):549-51. PubMed ID: 6415492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midtrimester pregnancy termination by intravaginal administration of prostaglandin E2.
    Surrago EJ; Robins J
    Contraception; 1982 Sep; 26(3):285-94. PubMed ID: 6756775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
    Owen J; Hauth JC
    Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-balloon instillation device for second-trimester abortion. Outcome in 340 consecutive cases.
    Abramovici H; Bornstein J; Ben-David Y; Yishai D; Rofe A; Atad J
    J Reprod Med; 1995 Jan; 40(1):56-62. PubMed ID: 7722978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 suppositories as a second-trimester abortifacient.
    Rakhshani R; Grimes DA
    J Reprod Med; 1988 Oct; 33(10):817-20. PubMed ID: 3193412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal PGE2 and intraamniotic PGF2 alpha for the termination of second trimester pregnancy.
    Farmakides G; Schulman H; Fayemi A; Fleischer A; Mitchell J; Blattner P
    Acta Chir Hung; 1986; 27(3):137-42. PubMed ID: 3469840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.